USD
EUR
GBP
CAD
AUD
CHF
HKD
JPY
RUB
BRL
CLP
NOK
DKK
SEK
KRW
ILS
MXN
CNY
SAR
SGD
NZD
ARS
INR
COP
AED
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
0
Home
Products
Peptides
Nootropics
Steriods
Sarms
Custom synthesis
Others
About Us
About Us
Sitemap
FAQ
Blog
News
Download
Contact Us
Home
>
News
News
The epilepsy treatment drug: Cenobamate
Apr 24, 2023
04-24
2023
Chemical Name: Cenobamate
CAS No.: 913088-80-9
DAYBUE (Trofinetide) Approved by the FDA, Expected to Be Available at the End of Next Month.
Mar 31, 2023
03-31
2023
DAYBUE (trofinetide CAS 853400-76-7) approved by the FDA, expected to be available at the end of next month.
Rett, commonly known as Rett syndrome, is one of the most common genetic causes of severe mental impairment in the world.
Trofinetide is a new IGF-1 amino-terminal tripeptide analogue that is being developed to treat the main symptoms of Rett syndrome by lowering neuroinflammation and promoting synaptic function.
"Myopia Cure" - Are Low Concentration Atropine Eye Drops Effective?
Mar 31, 2023
03-31
2023
"Myopia Cure" - Are Low Concentration Atropine(CAS 51-55-8) Eye Drops Effective?
I. Substantially delay the progression of myopia
2. high level of security
3. Easy to use
4. Low cost
Pfizer's New Nasal Spray for Acute Migraine Treatment Approved by the FDA
Mar 31, 2023
03-31
2023
ZAVEGEPANT (ZAVZPRET) CAS: 1337918-83-8
Pfizer's New Nasal Spray for Acute Migraine Treatment Approved by the FDA
Pfizer conducted a two-line phase III trial to demonstrate the safety and efficacy of this product in order to obtain FDA approval.
The Benefits of Piracetam: Improving Memory and Focus
Mar 31, 2023
03-31
2023
Approved Drugs by the FDA in January 2023
Mar 30, 2023
03-30
2023
Drugs approved for marketing by the FDA in January 2023
Leqembi (lecanemab-irmb)
Jayprica (Pirtobrutinib)
Brenzavvy (bexagliflozin)
Orserdu (elacestrant )
Olutasidenib---A New Drug for Leukemia
Mar 29, 2023
03-29
2023
New leukemia drug Olutasidenib
1. imatinib mesylate
2. Dasatinib
3.Nilotinib
4. Bosutinib
5. ibrutinib
6. idelalisib
7. Venetoclax
8. midostaurin
9. Enasidenib
10. ivosidenib
11. gilteritinib
12. vincristine
Top 10 Small Molecule Drugs of 2023
Mar 28, 2023
03-28
2023
Top 10 Small Molecule Drugs of 2023 Deucravacitinib, MRTX1133, Resmetirom, Voxelotor (Oxbryta), Mavacamten (Camzyos), ziftomenib (KO-539), IL-17, YCT529, emraclidine (enlaridine, CVL-231), Avacopan
Where Can I Get the Best HHCp Gummies in 2023?
Mar 27, 2023
03-27
2023
Investigate reliable brands: Search for genuine products that adhere to stringent quality standards and have a positive market reputation.
Fluxametamide CAS: 928783-29-3
Mar 05, 2023
03-05
2023
Fluxametamide is an antagonist of GABA- and glutamate-gated chloride channels. It inhibits GABA and glutamate-induced currents in M. domestica GABACls and GluCls, with IC50 values of 1.95 (1.18-3.21) nM and 225 (137-372) nM, respectively, and has potent antagonistic activity against T. urticae GABACls, with an IC50 of 0.219 (0. Fluxametamide suppresses GABA responses in wild-type L. striatellus GABACls with IC50 values of 1.40 (0.57-3.29) nM and 3.51 (2.17-5.69) nM in A2′N mutant GABACls. Moreover, at 10 M, Fluxametamide hardly suppresses GABA (EC50)-induced currents in rat GABACls and has little effect on glycine (EC50)-induced currents in human 1 GlyCls.
1
...
2
3
4
5
6
7
8
page:
Go